These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9037577)

  • 21. Unexpected hypotension in catecholamine reversal: a case report.
    Okada Y; Ishi W; Narumiya H; Liduka R
    J Med Case Rep; 2017 Oct; 11(1):285. PubMed ID: 28982383
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological profile of the new potent neuroleptic ocaperidone (R 79,598).
    Megens AA; Awouters FH; Meert TF; Schellekens KH; Niemegeers CJ; Janssen PA
    J Pharmacol Exp Ther; 1992 Jan; 260(1):146-59. PubMed ID: 1370538
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The dose-dependent effect of chronic administration of haloperidol, risperidone, and quetiapine on sexual behavior in the male rat.
    Zhang XR; Zhang ZJ; Jenkins TA; Cheng WR; Reynolds GP
    J Sex Med; 2011 Dec; 8(12):3345-53. PubMed ID: 20233290
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Intoxications with atypical antipsychotic drugs--data of the Acute Intoxication Unit in Wrocław].
    Magdalan J; Wasyko-Smolarek M; Antończyk A; Kochman K; Przewłocki M; Porebska B
    Przegl Lek; 2004; 61(4):392-6. PubMed ID: 15521612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Possible risperidone poisoning in a dog.
    Gough A
    Vet Rec; 2004 Jul; 155(5):156. PubMed ID: 15338714
    [No Abstract]   [Full Text] [Related]  

  • 26. Risperidone.
    Cohen LJ
    Pharmacotherapy; 1994; 14(3):253-65. PubMed ID: 7524043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overdose of risperidone.
    Brown K; Levy H; Brenner C; Leffler S; Hamburg EL
    Ann Emerg Med; 1993 Dec; 22(12):1908-10. PubMed ID: 7694530
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extrapyramidal side effects with risperidone and haloperidol at comparable D2 receptor occupancy levels.
    Knable MB; Heinz A; Raedler T; Weinberger DR
    Psychiatry Res; 1997 Sep; 75(2):91-101. PubMed ID: 9351491
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New clinical manifestations of acute risperidone poisoning.
    Dueñas-Laita A; Castro-Villamor MA; Martín-Escudero JC; Pérez-Castrillon JL
    J Toxicol Clin Toxicol; 1999; 37(7):893-5. PubMed ID: 10630278
    [No Abstract]   [Full Text] [Related]  

  • 30. [Hyperprolactinemia induced by neuroleptics].
    Lakartidningen; 2007 May 9-15; 104(19):1522. PubMed ID: 17550031
    [No Abstract]   [Full Text] [Related]  

  • 31. An efficient synthesis of risperidone via stille reaction: antipsychotic, 5-HT2, and dopamine-D2-antagonist.
    Kim DM; Kang MS; Kim JS; Jeong JH
    Arch Pharm Res; 2005 Sep; 28(9):1019-22. PubMed ID: 16212230
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of acute haloperidol or risperidone on subjective responses to methamphetamine in healthy volunteers.
    Wachtel SR; Ortengren A; de Wit H
    Drug Alcohol Depend; 2002 Sep; 68(1):23-33. PubMed ID: 12167550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is it possible to predict the clinical effects of neuroleptics from animal data? Part V: From haloperidol and pipamperone to risperidone.
    Janssen PA; Awouters FH
    Arzneimittelforschung; 1994 Mar; 44(3):269-77. PubMed ID: 7514873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risperidone: an analysis of the first three years in general use.
    Gutierrez-Esteinou R; Grebb JA
    Int Clin Psychopharmacol; 1997 Sep; 12 Suppl 4():S3-10. PubMed ID: 9352340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risperidone does not elevate neurotensin mRNA in rat nucleus accumbens and caudate-putamen.
    Mijnster MJ; Docter GJ; Voorn P
    Neuroreport; 1995 Nov; 6(16):2209-12. PubMed ID: 8595204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Acute poisoning by risperidone and ionic and electrocardiographic changes].
    Laroussinie G; Zenut M; Béal M; Bernard C; Lavarenne J
    Therapie; 1997; 52(2):155-6. PubMed ID: 9231512
    [No Abstract]   [Full Text] [Related]  

  • 37. Novel pharmacological approaches to the treatment of schizophrenia.
    Fink-Jensen A
    Dan Med Bull; 2000 Jun; 47(3):151-67. PubMed ID: 10913983
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined treatment of quetiapine with haloperidol in animal models of antipsychotic effect and extrapyramidal side effects: comparison with risperidone and chlorpromazine.
    Tada M; Shirakawa K; Matsuoka N; Mutoh S
    Psychopharmacology (Berl); 2004 Oct; 176(1):94-100. PubMed ID: 15083255
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The evolution of the serotonin-dopamine antagonist concept.
    Huttunen M
    J Clin Psychopharmacol; 1995 Feb; 15(1 Suppl 1):4S-10S. PubMed ID: 7730499
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biochemical evidence that the atypical antipsychotic drugs clozapine and risperidone block 5-HT(2C) receptors in vivo.
    Di Matteo V; Cacchio M; Di Giulio C; Di Giovanni G; Esposito E
    Pharmacol Biochem Behav; 2002 Apr; 71(4):607-13. PubMed ID: 11888552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.